X-52864781-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_133179.3(XAGE3):c.307G>A(p.Glu103Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,209,411 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 5 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000036 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000013 ( 0 hom. 5 hem. )
Consequence
XAGE3
NM_133179.3 missense
NM_133179.3 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 1.24
Genes affected
XAGE3 (HGNC:14618): (X antigen family member 3) This gene is a member of the XAGE subfamily, which belongs to the GAGE family. The GAGE genes are expressed in a variety of tumors and in some fetal and reproductive tissues. This gene is expressed in placenta and fetal liver/spleen, and may function in inhibiting cancer cell growth. The protein encoded by this gene shares a sequence similarity with other GAGE/PAGE proteins. Because of the expression pattern and the sequence similarity, this protein also belongs to a family of CT (cancer-testis) antigens. Alternative splicing of this gene generates 2 transcript variants differing in the 5' UTR. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10986826).
BS2
High Hemizygotes in GnomAdExome4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
XAGE3 | NM_133179.3 | c.307G>A | p.Glu103Lys | missense_variant | 4/5 | ENST00000346279.4 | NP_573440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
XAGE3 | ENST00000346279.4 | c.307G>A | p.Glu103Lys | missense_variant | 4/5 | 1 | NM_133179.3 | ENSP00000303061.3 | ||
XAGE3 | ENST00000375491.7 | c.307G>A | p.Glu103Lys | missense_variant | 4/5 | 1 | ENSP00000364640.3 |
Frequencies
GnomAD3 genomes AF: 0.0000358 AC: 4AN: 111798Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33956
GnomAD3 genomes
AF:
AC:
4
AN:
111798
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33956
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000546 AC: 1AN: 183156Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67676
GnomAD3 exomes
AF:
AC:
1
AN:
183156
Hom.:
AF XY:
AC XY:
1
AN XY:
67676
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000128 AC: 14AN: 1097561Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 5AN XY: 363049
GnomAD4 exome
AF:
AC:
14
AN:
1097561
Hom.:
Cov.:
29
AF XY:
AC XY:
5
AN XY:
363049
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000358 AC: 4AN: 111850Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34018
GnomAD4 genome
AF:
AC:
4
AN:
111850
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
34018
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2023 | The c.307G>A (p.E103K) alteration is located in exon 4 (coding exon 3) of the XAGE3 gene. This alteration results from a G to A substitution at nucleotide position 307, causing the glutamic acid (E) at amino acid position 103 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
M;M
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
B;B
Vest4
MVP
MPC
0.0056
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at